- 1-2-300! The biosimilar horde stands at the gate
- First approval for biosimilar infliximab, in South Korea (update)
- LG and Mochida strike secretive biosimilars alliance
- EMA publishes guideline to smooth the way to biosimilar MAbs
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.